Celcuity Inc. Schedules Release of Third Quarter 2021 Financial Results and Webcast/Conference Call
10/29/2021 - 09:00 AM
MINNEAPOLIS, MN / ACCESSWIRE / October 29, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, today announced that it will release its financial results for the third quarter 2021 after the stock market close on Monday, November 8, 2021. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Webcast and Conference Call Information
To participate in the teleconference, domestic callers should dial 1-877-407-0784 and international callers should dial 1-201-689-8560 and reference conference ID: 13724062. A live webcast presentation can also be accessed using this weblink: https://78449.themediaframe.com/dataconf/productusers/vvdb/mediaframe/46959/indexl.html . A replay of the webcast will be available on the Celcuity website following the live event.
About Celcuity
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic and therapeutic strategy. Its CELsignia companion diagnostic platform is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from already approved targeted therapies. Its therapeutic efforts are focused on in-licensing and developing molecularly targeted therapies that address the same cancer driver its companion diagnostics can identify. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at www.celcuity.com .
Contacts:
Celcuity Inc. bsullivan@celcuity.com vhahne@celcuity.com
ICR Westwicke robert.uhl@westwicke.com
SOURCE: Celcuity Inc.
https://www.accesswire.com/670329/Celcuity-Inc-Schedules-Release-of-Third-Quarter-2021-Financial-Results-and-WebcastConference-Call
CELC Rankings
#2062 Ranked by Stock Gains
CELC Stock Data
Industry
Medical Laboratories
Sector
Health Care and Social Assistance
Tags
Commercial Services, Miscellaneous Commercial Services, Health Care and Social Assistance, Medical Laboratories
About CELC
celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.
